Split Becomes Effective Monday, November 11, 2024Shareholder- and Board-Approved Action Reduces Shares Outstanding to 313,235 from 31 Million, Ensures Continued Compliance with Nasdaq Listing ...

Quarter Results07.11.2024 / 12:30 CET/CESTThe issuer is solely responsible for the content of this announcement.Immunic, Inc. Reports Third Quarter 2024 Financial Resultsand Provides Corporate Update– ...

Professor Meritxell Huch, a director at the Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany receives this year’s Otto Bayer Award for her pioneering research on human ...

The UK Dementia Research Institute has today announced multimillion major new government funding to “supercharge” advances in research and develop and deliver new solutions for people living with or ...

PulseSight Therapeutics SAS, an ophthalmology biotech company developing disruptive non-viral vectorized therapies with minimally-invasive delivery technology, has presented new data on its lead ...

Scottish scientists have developed a low-cost, flexible device that can help prevent blood clots for patients after an operation.

New research into a chemical produced by a caterpillar fungus that has shown promise as a possible cancer treatment has revealed how it interacts with genes to interrupt cell growth signals. The ...

The third quarter of 2024 presented Genmab with additional opportunities to progress towards our goal of fundamentally transforming the lives of people with cancer and other serious diseases. The ...

Bristol Myers Squibb today announced the appointment of Karen Costello as the new General Manager for its commercial operations in Ireland. In this new role, Karen will lead the delivery of Bristol ...

Quarter Results/9 Month figuresRHÖN-KLINIKUM AG continues solid performance in the first nine months – outlook confirmed   07.11.2024 / 08:59 CET/CESTThe issuer is solely responsible for the content ...

Enteralia Bioscience SRL Acquires TFarma to Strengthen Presence in Italy's Nutraceutical and Medical Device MarketMILAN, ITALY / ACCESSWIRE / November 7, 2024 / Enteralia Bioscience SRL ("Enteralia") ...

The global microfluidics market is on track for exceptional expansion, with projections showing a rise from USD 7,711.9 million in 2023 to an extraordinary USD 23,739.1 million by 2033, representing a ...